Clinical Trials Logo

Epilepsy clinical trials

View clinical trials related to Epilepsy.

Filter by:

NCT ID: NCT04376671 Completed - Epilepsy Clinical Trials

Quantitative EEG Markers in Mild Cognitive Impairment in Epilepsy

Start date: March 1, 2019
Phase:
Study type: Observational

Epileptic patients are plighted with limited daily activities, social dysfunction, family conflicts and cognitive impairment. Most of the studies had showed that cognitive disorders were frequent in patients with epilepsy.The cognitive impairment has been reported in around 25% of epileptic patients.

NCT ID: NCT04357912 Completed - Epilepsy Clinical Trials

Utilizing Activity Trackers to Promote Physical Activity in People With Epilepsy: Can we Make a Difference?

Start date: June 16, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate standard of care exercise education alone or in combination with a wearable physical activity tracker in people with epilepsy (PWE) to determine the most effective way to increase physical activity and measure impact on depression, anxiety, quality of life, sleep, and seizure frequency.

NCT ID: NCT04357236 Completed - Clinical trials for Benign Epilepsy With Centrotemporal Spikes

18F-FDG PET Imaging Analysis of Antiepileptic Drug Response in BECTS

Start date: June 1, 2019
Phase:
Study type: Observational

This original article is a novel investigation on the metabolic characteristics of different patterns of antiepileptic drug (AED) responses in benign epilepsy with centrotemporal spikes (BECTS) patients using 18F-FDG PET imaging. In this study, we demonstrated remitting-relapsing group showed more widespread hypo-metabolism regions than AED responders. Results indicated that metabolic differences had the ability to distinguish the remitting-relapsing patients from AED responders. 18F-FDG PET could be used as a marker to infer the current seizure activity of BECTS. We think that the established hybrid model based on PET and clinical features may be a critical reference for better personalized medication in patients with BECTS.

NCT ID: NCT04343352 Completed - Epilepsy Clinical Trials

Evaluation of the Efficiency of Mobile Application for Parents of Children With Epilepsy

Start date: October 17, 2020
Phase: N/A
Study type: Interventional

Introduction: support to family and child related to epilepsy, controls or when they come for urgent reasons. Solutions must be found to ensure its continuity. this support. The widespread use of the Internet today, e-health and health education is increasing day by day. Objective: The investigators research is planned to develop a mobile Epilepsy Training Program. Parents with children diagnosed with epilepsy and assessing its effectiveness. Material and Method: The research is a randomized controlled experimental study. An application was made to the Eskişehir Osmangazi University Clinical Research Ethics Committee and the ethics committee permission was obtained with the decision of 13.02.2020 dated 80558721-050.99-E.20230 and 2019-66 decision. Only volunteer participants will be included in the research. Its population study 3-6 years old children diagnosed with epilepsy Eskişehir City Hospital Child Neurology Outpatient Clinic between 01 September 2020 and 31 September 2021. The sample of the research will consist of parents who meet the inclusion criteria. research between these dates. Parents meeting research sample selection criteria The application was randomized as a control group according to the Parent Epilepsy Information Scale. Application group; will use the mobile application the investigators prepared for the parent. Control group will consist of parents who follow the hospital's treatment protocol. The investigators study Completed with a total of 60 parents, 30 of whom are determined by power analysis group. Statistical analysis will be done with SPSS package program. Keywords: Child, Epilepsy, Parent Education, Mobile Application, Child Nurse

NCT ID: NCT04313686 Completed - Epilepsy Clinical Trials

Mindfulness-based Intervention to Promote Psychological Wellbeing in People With Epilepsy

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

The efficacy of mindfulness-based intervention (MBI) for epilepsy has yet to be thoroughly investigated. Hence, the aim of the present study is to examine the effects of MBI on the psychological wellbeing of people with epilepsy (PWE) using a randomized trial design. Key outcomes include depression, anxiety and quality of life. Our primary objective was to evaluate the effect of mindfulness-based therapy on anxiety, depression, epilepsy specific QOL, and life satisfaction in PWE, applying the concept of Reliable Change Index. The secondary objective was to assess whether the results correlate with the level of mindfulness. Study results may be used to decide whether it is worth offering mindfulness training for PWE as an alternative therapy to cope and improve seizure management.

NCT ID: NCT04311151 Completed - Epilepsy Clinical Trials

Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior

VICE
Start date: January 12, 2017
Phase: N/A
Study type: Interventional

In Spain, an estimated 690,000 persons have epilepsy, of whom 270,000 have active epilepsy (defined as those who have had a seizure in the last 5 years). It is estimated that 30% of patients diagnosed with epilepsy are drug-resistant. Patients with loss of consciousness or impaired awareness during seizures are at higher risk of injury due to accidents. To prevent such injuries, it is important that patients are sufficiently knowledgeable about their disease to allow them to avoid risk behavior. In this project, we want to know if visualization of self seizures has an impact on the perception of the severity of the disease, as well as on the risky behavior habits.

NCT ID: NCT04309214 Completed - Epilepsy Clinical Trials

Market Research - Acceptability Study for New MCT Fat Products

Start date: November 26, 2018
Phase: N/A
Study type: Interventional

This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children, young people and adults with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood.

NCT ID: NCT04309149 Completed - Epilepsy Clinical Trials

Market Research - Acceptability Study for a Range of MCT Products

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children and young people with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood. Patients with a confirmed diagnosis of a fatty acid oxidation disorder, which requires a specialist diet including MCT will be included in this study

NCT ID: NCT04290611 Completed - Prostate Cancer Clinical Trials

a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY

VENDY
Start date: January 1, 2019
Phase:
Study type: Observational

Enzalutamide may lead to various adverse reactions. This study investigates reports of different neurological toxicities in the World Health Organization's (WHO) global database of individual safety case reports (VigiBase).

NCT ID: NCT04287881 Completed - Epilepsy Clinical Trials

Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke

Start date: October 31, 2019
Phase: N/A
Study type: Interventional

Adult onset epileptic seizures is rare and often associated with metabolic disorders, drugs and intracranial pathologies such as ischemia, hemorrhage or space-occupying lesions. Methylenetetrahydrofolate reductase (MTHFR) deficiency is one of the reasons that cause epileptic seizures in adults and can be ignored. MTHFR deficiency is an autosomal recessive disorder that results in hyperhomocysteinemia and causes a predisposition to venous and arterial thrombosis. The incidence of the polymorphism is around 40% in some countries. The aim of the retrospective study is to investigate the incidence of MTHFR deficiency in patients with adult-onset epileptic seizures.